tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
Holding VYNE?
Track your performance easily

VYNE Therapeutics (VYNE) Financial Statements

1,823 Followers

VYNE Therapeutics Financial Overview

VYNE Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.851; its P/E ratio is ―; VYNE Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 100.00K$ 198.00K$ 98.00K$ 76.00K$ 114.00K
Gross Profit$ 100.00K$ 200.00K$ 100.00K$ 52.00K$ 114.00K
EBIT$ -13.09M$ -10.40M$ -7.38M$ -6.83M$ -6.23M
EBITDA$ -13.60M$ -10.40M$ -7.38M$ -6.83M$ -6.23M
Net Income Common Stockholders$ -12.16M$ -9.41M$ -6.25M$ -6.19M$ -6.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 70.19M$ 78.10M$ 85.95M$ 93.25M$ 15.45M
Total Assets$ 76.20M$ 86.65M$ 91.68M$ 97.69M$ 19.27M
Total Debt$ ―$ 145.00K$ 180.00K$ 214.00K$ ―
Net Debt$ ―$ -77.96M$ -85.77M$ -93.04M$ ―
Total Liabilities$ 12.66M$ 11.78M$ 8.29M$ 8.95M$ 7.76M
Stockholders Equity$ 63.54M$ 74.87M$ 83.36M$ 88.73M$ 11.51M
Cash Flow-
Free Cash Flow$ -8.50M$ -8.50M$ -8.00M$ -5.14M$ -5.15M
Operating Cash Flow$ -8.50M$ -8.50M$ -8.00M$ -5.14M$ -5.15M
Investing Cash Flow$ -4.82M$ 19.02M$ -3.57M$ -62.35M-
Financing Cash Flow$ -2.00K$ -3.00K$ -4.00K$ 82.66M$ -47.00K
Currency in USD

VYNE Therapeutics Earnings and Revenue History

VYNE Therapeutics Debt to Assets

VYNE Therapeutics Cash Flow

VYNE Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis